Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Yale University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
melanomapembrolizumabrenal-cell-carcinoma
melanoma, renal cell carcinoma, brain metastases, pd1/pd-l1 experienced, pembrolizumab, lenvatinib, metastatic melanoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 901633
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.